Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$8.71 - $14.65 $10.4 Million - $17.6 Million
-1,198,520 Reduced 85.18%
208,473 $1.93 Million
Q4 2023

Feb 14, 2024

BUY
$7.89 - $13.14 $11.1 Million - $18.5 Million
1,406,993 New
1,406,993 $17.9 Million

Others Institutions Holding LUNG

About Pulmonx Corp


  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $236M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track This Portfolio

Track Divisadero Street Capital Management, LP Portfolio

Follow Divisadero Street Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Divisadero Street Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Divisadero Street Capital Management, LP with notifications on news.